stocksbrew
Market
Explore
Watchlist
Market
Explore
Watchlist
stocksbrew.

Analyse any US stock, then track the ones you care about.

Appearance

Product

  • Market today
  • Explore
  • Watchlist
  • Earnings
  • US stocks
  • AI agent access

Free tools

  • Should I Buy?
  • Compare stocks
  • Portfolio Analyzer
  • Market Heat
  • Screens

Resources

  • Learn & guides
  • Blog
  • Use cases
  • Developer API

Company

  • About
  • Pricing
  • Contact
  • Terms of service
  • Privacy policy

© 2026 stocksbrew. All rights reserved.

stocksbrew provides market data and analytics for informational purposes only. Nothing here is investment advice. Past performance does not guarantee future results.

stocksbrew — Verified on SubmitForBacklinksFeatured on ScrollLaunchLaunched on FazierStocksBrew - Featured on Startup FameFeatured on Wired Business
DV
DVA stock logo

DaVita

Large Cap · Healthcare · Medical Care Facilities

$177.83+$1.13 (+0.64%)
DV
DVA stock logo

DaVita

Large Cap · Healthcare · Medical Care Facilities

$177.83+$1.13 (+0.64%)

Stock analysis

$177.83+$1.13 (+0.64%)

Get the AI take on DVA

Track it to unlock the price chart, verdict and what could change it.

  • ✓Live price chart
  • ✓A clear accumulate, trim or avoid call

Free to track. No card required.

Stock Fundamentals & Key Indicators

52-week range
Low$101.00
High$239.64
Today $177.83
RSI (14)
17.8Oversold
03070100

Overall score

67/100

See the full financial picture

Open the five-year record, valuation checks and Wall Street view behind these scores.

  • ✓5 years of revenue, profit and cash flow
  • ✓Valuation and balance-sheet checks
  • ✓Business and geographic mix
  • ✓Analyst targets and recommendation trend

Free for 3 days, then $9/mo. Cancel anytime.

Analyst Rating and Sentiment

Analyst price targets

Lowest

$165

Current price

$177.83

Median target

$220

Highest

$270

LowHigh

Operating Record

Revenue

What's working

  • Forward P/E: Investors aren't pricing in much earnings growth, so there's room to be pleasantly surprised.
  • Price / sales: You're paying a modest amount for each dollar of revenue coming in.

What to watch

  • Debt exceeds cash by $12.7B, increasing balance-sheet pressure, a warning sign.
  • Debt / equity: Heavy borrowing means a downturn would hit harder than it otherwise would.

What the market charges

Forward P/E

Favorable · 32% below avg

11.41x

Price / sales

Strong · Priced modestly against the revenue it brings in

0.82x

Price / FCF

Strong · Priced well within what its cash flow supports

7.13x

EV / EBITDA

Strong · Operating earnings comfortably support this price

8.56x

How efficiently it compounds

ROIC

Reasonable · A middling return on the capital it puts to work

12.3%

ROE

Favorable · 635.3% - strong capital efficiency

88.5%

Debt / equity

Rich · Carrying more debt than equity can comfortably absorb

12.42x

Current ratio

Reasonable · Just enough on hand to cover near-term bills

1.47x

Peer Comparison

CompanyMkt capP/ERev growthScore
DV
DVA stock logo
DVADaVita
$11.49B15.2+6.5%67
GM
GMED stock logo
GMEDGlobus Medical
$11.53B22.0+19.7%78
IN
INDV stock logo
INDVIndivior
$4.60B13.9+13.5%77
DX
DXCM stock logo
DXCMDexcom
$33.87B35.4+15.5%77
LL
LLY stock logo
LLYEli Lilly and Company
$1.11T40.1+49.6%76